- The future of NSCLC treatment: what’s in store for the therapeutic space?
- Six biotech companies leading the charge in hemophilia treatment
- U.S. budget cuts: what is the impact on therapeutic research?
- The past, present, and future of genome sequencing
- AI in biotech today, and how it will impact the industry tomorrow
- The emergence of BTK inhibitors in multiple sclerosis treatment: Companies close in on approval
- Tariffs and trade war: A guide for expanding biotech business internationally
- Seven biotechs to watch in the hepatitis B space
- Biomaterials in construction: meet the startups reinventing our buildings
- HIV innovation: Six companies developing new treatments in 2025
- Beyond CRISPR: Brink Therapeutics raises $4 million with engineered recombinases
- The AI race in biotech: Is Europe falling behind the US and China?
- Metabolomics: The study of biology’s dark matter
- Basel: What’s behind the success of one of Europe’s leading biotech hubs?
- How nanobodies will revolutionize immunotherapy